# A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

> **NCT02354859** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 119 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Gallium nitrate
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02354859
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2019-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354859, "A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02354859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*